| Identification | Back Directory | [Name]
1-1(Z)-Hexadecenyl-2-Palmitoyl-sn-glycero-3-PE | [CAS]
1199257-33-4 | [Synonyms]
1-1(Z)-Hexadecenyl-2-Palmitoyl-sn-glycero-3-PE | [Molecular Formula]
C37H74NO7P | [MOL File]
1199257-33-4.mol | [Molecular Weight]
675.96 |
| Chemical Properties | Back Directory | [Boiling point ]
714.0±70.0 °C(Predicted) | [density ]
0.992±0.06 g/cm3(Predicted) | [solubility ]
Chloroform: 3 mg/ml | [form ]
A crystalline solid | [pka]
1.18±0.50(Predicted) |
| Hazard Information | Back Directory | [Description]
1-1(Z)-Hexadecenyl-2-palmitoyl-sn-glycero-3-PE is a plasmalogen that contains 1(Z)-hexadecenoic acid and palmitic acid at the sn-1 and sn-2 positions, respectively. | [Uses]
1-1(Z)-Hexadecenyl-2-palmitoyl-sn-glycero-3-PE (compound 18) is a lipid metabolite associated with central nervous system diseases[1]. | [Definition]
ChEBI: 1-(hexadec-1-enyl)-2-hexadecanoyl-sn-glycero-3-phosphoethanolamine zwitterion is a 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine zwitterion in which the alk-1-enyl and acyl group are specified as (Z)-hexadec-1-enyl and hexadecanoyl (palmitoyl) respectively. It is a tautomer of a 1-(hexadec-1-enyl)-2-hexadecanoyl-sn-glycero-3-phosphoethanolamine. | [References]
[1] LIPIDOMICS APPROACHES FOR CENTRAL NERVOUS SYSTEM DISORDERS. WO20090305323. |
|
|